Who owns Relmada Therapeutics Inc?
- Ticker: RLMD
- CUSIP Number: 75955j402
Tip: Access positions for across all investors
Analyze quarterly positions in Relmada Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Relmada Therapeutics stock
Who bought or sold Relmada Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.3M | $5.4M | 0% | Dec 2023 |
|
| Parsons Capital Management | 974k | $4.5M | 2% | Mar 2024 |
|
| Opaleye Management | 877k | $3.6M | 2823% | Dec 2023 |
|
| Palo Alto Investors | 732k | $3.0M | 0% | Dec 2023 |
|
| Citadel Advisors | 481k | $2.0M | -7% | Dec 2023 |
|
| Two Sigma Advisers | 328k | $1.4M | 100% | Dec 2023 |
|
| Two Sigma Investments | 303k | $1.3M | 54% | Dec 2023 |
|
| Mirae Asset Global Investments | 270k | $1.1M | 4% | Dec 2023 |
|
| Point72 Asset Management | 250k | $1.0M | 100% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 225k | $931k | 4434% | Dec 2023 |
|
| Jacobs Levy Equity Management | 214k | $884k | 70% | Dec 2023 |
|
| Bank of America Corporation | 211k | $872k | -1% | Dec 2023 |
|
| Millennium Management | 199k | $824k | -19% | Dec 2023 |
|
| Guild Investment Management | 191k | $888k | -10% | Mar 2024 |
|
| GSA Capital Partners | 185k | $764k | -6% | Dec 2023 |
|
| Marshall Wace | 154k | $636k | 100% | Dec 2023 |
|
| Barclays | 146k | $604k | 0% | Dec 2023 |
|
| UBS Group | 126k | $521k | 0% | Dec 2023 |
|
| We Are One Seven | 100k | $414k | 0% | Dec 2023 |
|
| Federated Investors | 100k | $413k | -13% | Dec 2023 |
|
| apricus wealth | 79k | $327k | 2% | Dec 2023 |
|
| Dimensional Fund Advisors | 74k | $306k | 0% | Dec 2023 |
|
| Squarepoint Ops | 73k | $304k | 122% | Dec 2023 |
|
| Citigroup | 73k | $303k | -27% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 61k | $253k | -30% | Dec 2023 |
|
| ADAR1 Capital Management | 59k | $243k | 100% | Dec 2023 |
|
| Simplex Trading | 47k | $217k | -17% | Mar 2024 |
|
| Ikarian Capital | 40k | $167k | 0% | Dec 2023 |
|
| Meyer Handelman | 33k | $151k | 0% | Mar 2024 |
|
| AlTi Global | 32k | $131k | 100% | Dec 2023 |
|
| Horizon Kinetics Asset Management | 30k | $124k | 100% | Dec 2023 |
|
| Wolverine Trading | 28k | $116k | 100% | Dec 2023 |
|
| Pegasus Asset Management | 27k | $112k | 0% | Dec 2023 |
|
| Tortoise Investment Management | 22k | $90k | 0% | Dec 2023 |
|
| Mariner Wealth Advisors | 21k | $86k | -10% | Dec 2023 |
|
| Spotlight Asset Group | 20k | $60k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 19k | $78k | 2088% | Dec 2023 |
|
| PDT Partners | 15k | $62k | 0% | Dec 2023 |
|
| Stratos Wealth Partners | 14k | $66k | -15% | Mar 2024 |
|
| Charles Schwab Investment Management | 13k | $52k | 0% | Dec 2023 |
|
| Jane Street | 12k | $50k | 100% | Dec 2023 |
|
| D. E. Shaw & Co | 11k | $44k | -45% | Dec 2023 |
|
| Bedel Financial Consulting | 10k | $41k | 0% | Dec 2023 |
|
| Cutler | 9.0k | $41k | -3% | Mar 2024 |
|
| Royal Bank of Canada | 4.2k | $17k | 611% | Dec 2023 |
|
| Hexagon Capital Partners | 4.0k | $19k | 0% | Mar 2024 |
|
| Brown Brothers Harriman & Co. | 3.0k | $12k | 0% | Dec 2023 |
|
| Lindbrook Capital | 2.5k | $12k | 0% | Mar 2024 |
|
| Acima Private Wealth | 1.8k | $7.6k | 0% | Dec 2023 |
|
| American Capital Advisory | 1.2k | $5.0k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 1.2k | $4.9k | 0% | Dec 2023 |
|
| GAMMA Investing | 569.00 | $2.6k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 540.00 | $2.2k | 2% | Dec 2023 |
|
| Fortitude Family Office | 340.00 | $1.6k | 0% | Mar 2024 |
|
| Massmutual Trust | 113.00 | $524.998000 | 0% | Mar 2024 |
|
| Russell Investments | 53.00 | $219.001300 | 0% | Dec 2023 |
|
| Advisor Group Holdings | 27.00 | $111.998700 | 0% | Dec 2023 |
|
| Front Row Advisors | 6.00 | $25.000200 | 0% | Dec 2023 |
|
Who sold out of Relmada Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| T. Rowe Price Associates | Sep 2023 | 159k | $478k |
| Schonfeld Strategic Advisors | Sep 2023 | 109k | $328k |
| Voloridge Investment Management | Sep 2023 | 91k | $274k |
| TD Asset Management | Sep 2023 | 25k | $75k |
| Occudo Quantitative Strategies | Sep 2023 | 23k | $69k |
| Sargent Investment Group | Sep 2023 | 16k | $49k |
| Goldman Sachs Group | Sep 2023 | 13k | $39k |
| Bank of New York Mellon | Dec 2023 | 11k | $46k |
| Savior | Sep 2023 | 3.5k | $11k |